0000874716-24-000042.txt : 20240216
0000874716-24-000042.hdr.sgml : 20240216
20240216175800
ACCESSION NUMBER: 0000874716-24-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schreck Michael
CENTRAL INDEX KEY: 0002004990
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 24649867
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
wk-form4_1708124258.xml
FORM 4
X0508
4
2024-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0002004990
Schreck Michael
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
0
Common Stock
2024-02-14
4
M
0
80
0
A
615
D
Common Stock
2024-02-14
4
M
0
118
0
A
733
D
Common Stock
2024-02-14
4
M
0
170
0
A
903
D
Common Stock
2024-02-14
4
F
0
117
560.56
D
786
D
Non-Qualified Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
5407
0
A
2034-02-13
Common Stock
5407
5407
D
Incentive Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
178
0
A
2034-02-13
Common Stock
178
178
D
Restricted Stock Unit
2024-02-14
4
A
0
1204
0
A
Common Stock
1204
1204
D
Restricted Stock Unit
2024-02-14
4
M
0
80
0
D
Common Stock
80
80
D
Restricted Stock Unit
2024-02-14
4
M
0
118
0
D
Common Stock
118
234
D
Restricted Stock Unit
2024-02-14
4
M
0
170
0
D
Common Stock
170
508
D
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2022.
Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2023.
Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024.
/s/ Lily J. Lu, Attorney-in-Fact for Michael Schreck
2024-02-16